Massimo Mallardo

University of Naples Federico II — Italy

Immunology and Microbiology · Life Sciences

1h-index10citations18works0.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(17), vaccines and immunoinformatics approaches(17), Monoclonal and Polyclonal Antibodies Research(15), Virus-based gene therapy research(1), CAR-T cell therapy research(1)

Publications18 total

Impact of STING deficiency on immune response and macrophage polarization 2407
The Journal of Immunology·2025Open Access
Supplementary Table 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Data from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Data from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 6 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Table 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 6 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 4 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 2 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 4 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 2 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
Cancer Immunology Research·2024· 10 citedOpen Access

Frequent Co-authors

Carmen Caiazza(18), Irene Garzia(17), Linda Nocchi(17), Lidia Avalle(17), Fulvia Troise(17), Guido Leoni(17), Laura Seclì(17), Laura Antonucci(17), Gabriella Cotugno(17), Simona Allocca(17), Giuseppina Colonna Romano(17), Laura Conti(17), Valeria Poli(17), Elisa Scarselli(17), Anna Morena D’Alise(17), Renata Palladino(1), Cássia Alves Sérgio(1), S. Crupi(1), Camilla Canale(1), Teresa Brusco(1)